[18F]fluoro-deoxy-glucose folate: A novel PET radiotracer with improved in vivo properties for folate receptor targeting

Bioconjugate Chemistry

Volumn 23, Issue 4, 2012, Pages 805-813

  Fischer, Cindy R ^a   Müller, Cristina ^b   Reber, Josefine ^b   Müller, Adrienne ^a   Krämer, Stefanie D ^a   Ametamey, Simon M ^a   Schibli, Roger ^a,b  

^a ETH ZURICH   (Switzerland)

^b ETH Zurich   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GLUCOSE; ORGANIC ACIDS; RADIOACTIVE TRACERS; RADIOACTIVITY; TUMORS;

ACTIVATED MACROPHAGES; AUTOIMMUNE DISEASE; FOLATE RECEPTOR; FOLATES; FOLIC ACIDS; IN-VIVO; INFLAMMATORY DISEASE; PROPERTY; RECEPTOR TARGETING; Β ISOFORMS;

POSITRON EMISSION TOMOGRAPHY;

2 DEOXY 2 FLUOROGLUCOPYRANOSYL AZIDE F 18; FLUORODEOXYGLUCOSE F 18; FLUORODEOXYGLUCOSE FOLATE F 18; FOLATE ALKYNE; FOLATE RECEPTOR; FOLIC ACID DERIVATIVE; GLUCOSE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; (18F)FLUORO DEOXY GLUCOSE FOLATE; (18F)FLUORO-DEOXY-GLUCOSE FOLATE; ALKYNE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FOLATE RECEPTOR 1; FOLATE RECEPTOR 2; FOLIC ACID; MONOSACCHARIDE; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLICK CHEMISTRY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; DRUG URINE LEVEL; FEMALE; GALLBLADDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; KIDNEY; LIGAND BINDING; LIVER; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIOCHEMISTRY; RECEPTOR UPREGULATION; TUMOR XENOGRAFT; ANIMAL; CELL STRAIN KB; CELL TRANSFORMATION; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; METHODOLOGY; PATHOLOGY; PROTEIN BINDING; SCINTISCANNING; UTERINE CERVIX TUMOR;

ALKYNES; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CLICK CHEMISTRY; FEMALE; FOLATE RECEPTOR 1; FOLATE RECEPTOR 2; FOLIC ACID; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KB CELLS; MICE; MONOSACCHARIDES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOACTIVE TRACERS; RADIOCHEMISTRY; UTERINE CERVICAL NEOPLASMS;

EID: 84859990896     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200660z     Document Type: Article

References (39)

1. Low, P. S., Henne, W. A., and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120-129.
2. Sega, E. I., and Low, P. S. (2008) Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev. 27, 655-664.
3. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., and Kamen, B. A. (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52, 3396-3401.
4. Parker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., and Leamon, C. P. (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338, 284-293. (Pubitemid 40312593)
5. Ke, C. Y., Mathias, C. J., and Green, M. A. (2004) Folate-receptor- targeted radionuclide imaging agents. Adv. Drug Deliv. Rev. 56, 1143-1160. (Pubitemid 38499700)
6. Paulos, C. M., Turk, M. J., Breur, G. J., and Low, P. S. (2004) Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv. Drug Delivery Rev. 56, 1205-1217. (Pubitemid 38496516)
7. Müller, C., and Schibli, R. (2011) Folic acid conjugates for nuclear imaging of folate receptor-positive cancer. J. Nucl. Med. 52, 1-4.
8. Müller, C., and Schibli, R. (2011) Folate Receptor-Targeted Radionuclide Imaging Agents, Targeted Drug Strategies for Cancer and Inflammation (Jackman, A. L., and Leamon, C. P., Eds.) pp 65-92, Chapter 4, Springer Science, New York.
9. Fisher, R. E., Siegel, B. A., Edell, S. L., Oyesiku, N. M., Morgenstern, D. E., Messmann, R. A., and Amato, R. J. (2008) Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J. Nucl. Med. 49, 899-906. (Pubitemid 351793430)
10. Leamon, C. P., and Reddy, J. A. (2004) Folate-targeted chemotherapy. Adv. Drug Delivery Rev. 56, 1127-1141. (Pubitemid 38496512)
11. Li, J., Sausville, E. A., Klein, P. J., Morgenstern, D., Leamon, C. P., Messmann, R. A., and LoRusso, P. (2009) Clinical pharmacokinetics and exposure-toxicity relationship of a folate-vinca alkaloid conjugate EC145 in cancer patients. J. Clin. Pharmacol. 49, 1467-1476.
12. Konner, J. A., Bell-McGuinn, K. M., Sabbatini, P., Hensley, M. L., Tew, W. P., Pandit-Taskar, N., Els, N. V., Phillips, M. D., Schweizer, C., Weil, S. C., Larson, S. M., and Old, L. J. (2010) Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study. Clin. Cancer Res. 16, 5288-5295.
13. Matteson, E. L., Lowe, V. J., Prendergast, F. G., Crowson, C. S., Moder, K. G., Morgenstern, D. E., Messmann, R. A., and Low, P. S. (2009) Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical FolatescanTM. Clin. Exp. Rheum. 27, 253-259.
14. Lu, Y. J., Stinnette, T. W., Westrick, E., Klein, P. J., Gehrke, M. A., Cross, V. A., Vlahov, I. R., Low, P. S., and Leamon, C. P. (2011) Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Arthritis Res. Ther. 13, R56.
15. Yi, Y. S., Ayala-Lopez, W., Kularatne, S. A., and Low, P. S. (2009) Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies. Mol. Pharmaceutics 6, 1228-1236.
16. Feng, Y., Shen, J. Y., Streaker, E. D., Lockwood, M., Zhu, Z. Y., Low, P. S., and Dimitrov, D. S. (2011) A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity. Arthritis Res. Ther. 13, R59.
17. Herzog, H. (2001) In vivo functional imaging with SPECT and PET. Radiochim. Acta 89, 203-214.
18. Ametamey, S. M., Honer, M., and Schubiger, P. A. (2008) Molecular imaging with PET. Chem. Rev. 108, 1501-1516. (Pubitemid 351796395)
19. 18F for PET imaging of folate receptor-positive tumors. J. Nucl. Med. 47, 1153-1160.
20. 18F-labeled folic acid derivative. Bioconjugate Chem. 19, 2462-2470.
21. Al Jammaz, I., Al-Otaibi, B., Amer, S., and Okarvi, S. M. (2011) Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptorpositive tumors. Nucl. Med. Biol. 38, 1019-1028.
22. 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors. J. Nucl. Med. 51, 1756-1762.
23. 18F-labeling and glycosylation by click chemistry. Carbohydr. Res. 344, 753-761.
24. 18F-glycopeptides as effective imaging probes for positron emission tomography. Angew. Chem., Int. Ed. 49, 976-979.
25. Baumann, C. A., Mu, L. J., Wertli, N., Krämer, S. D., Honer, M., Schubiger, P. A., and Ametamey, S. M. (2010) Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands. Bioorg. Med. Chem. 18, 6044-6054.
26. 99mTc-based radiopharmaceutical. Bioconjugate Chem. 13, 1200-1210.
27. 99mTc-EC20 for imaging folate receptor-positive tumors. J. Nucl. Med. 45, 857-866.
28. 2-receptors in mice using quad-HIDAC PET. J. Nucl. Med. 45, 464-470.
29. 3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue. Bioconjugate Chem. 19, 1689-1695.
30. 99mTc-EC20 in xenografted and syngeneic tumorbearing mice. Mol. Pharmaceutics 7, 597-604.
31. Müller, C., Forrer, F., Schibli, R., Krenning, E. P., and de Jong, M. (2008) SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. J. Nucl. Med. 49, 310-317. (Pubitemid 351225671)
32. 18F]-fluoro-2-deoxy- Dglucose using aminopolyether supported nucleophilic-substitution. J. Nucl. Med. 27, 235-238.
33. Rostovtsev, V. V., Green, L. G., Fokin, V. V., and Sharpless, K. B. (2002) A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. Angew. Chem., Int. Ed. 41, 2596-2599. (Pubitemid 34803480)
34. Tornoe, C. W., Christensen, C., and Meldal, M. (2002) Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 67, 3057-3064. (Pubitemid 34457265)
35. Moses, J. E., and Moorhouse, A. D. (2007) The growing applications of click chemistry. Chem. Soc. Rev. 36, 1249-1262.
36. Müller, C., Mindt, T. L., de Jong, M., and Schibli, R. (2009) Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy. Eur. J. Nucl. Med. Mol. Imaging 36, 938-946.
37. 18F-Labeled 3-deoxy-3-fluoro-D-glucose for the study of regional metabolism in the brain and heart. J. Nucl. Med. 22, 138-144.
38. 18F-NaF deposition. J. Nucl. Med. 51, 1826-1829.
39. Leamon, C. P., Reddy, J. A., Klein, P. J., Vlahov, I. R., Dorton, R., Bloomfield, A., Nelson, M., Westrick, E., Parker, N., Bruna, K., Vetzel, M., Gehrke, M., Nicoson, J. S., Messmann, R. A., LoRusso, P. M., and Sausville, E. A. (2011) Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications. J. Pharmacol. Exp. Ther. 336, 336-343.